Our Speakers



Our Speakers

Prof. Frank Dekker
Prof. Frank Dekker

Professor, Medicinal Chemistry, Chemical Biology University of Groningen, Netherlands

Rémi Terranova
Rémi Terranova

Novartis Institutes for BioMedical Research, Switzerland

Rene Bartz
Rene Bartz

Manager, Development Products, 4SC, Germany

Alfredo Budillon
Alfredo Budillon

Chief Experimental Pharmacology Unit Department of Research

Istituto Nazionale Tumori, Italy

Magnus Ivarsson
Magnus Ivarsson

VP, Head of Discovery

Rodin Therapeutics, USA

Wouter De Jounge
Wouter De Jounge

Professor

NARCIS, Netherlands

Christopher Schofield
Christopher Schofield

Head of Organic Chemistry, University of Oxford and fellow of Royal society, UK

Shailendra Singh (Shelly)
Shailendra Singh (Shelly)

Chief Operating Officer

MarketsandMarkets

Inma Rioja
Inma Rioja

Senior Director & Portfolio Research Lead at Epigenetics DPU

GSK

Dr. Tamara Maes
Dr. Tamara Maes

Chief Scientific Officer, Oryzon, Spain

Mikhail Spivakov
Mikhail Spivakov

Group leader and Honorary Senior Lecturer, MRC London Institute of Medical Sciences

Imperial College

Nathaniel I. Martin
Nathaniel I. Martin

Professor, Biological Chemistry

University of Sylvius

Marcus Buschbeck
Marcus Buschbeck

Group Leader

Josep Carreras Leukaemia Institute

Gavin Reynolds
Gavin Reynolds

Professor Emeritus

Queen's University Belfast

Manfred Jung
Manfred Jung

Professor, Pharmaceutical Chemistry

University of Freiburg

Ronan Murphy
Ronan Murphy

Assciate Editor, Clinical Epigenetics

Dublin City University

Panagis Filippakopoulos
Panagis Filippakopoulos

Associate Professor, Structural Genomics Consortium

University of Oxford

Rachel Grimley
Rachel Grimley

Executive Director, Global Head, Mechanistic Biology & Profiling

AstraZeneca

Dan Dransfield
Dan Dransfield

Vice President, Biology

Epizyme


Loading...